Quantcast
Last updated on April 16, 2014 at 5:23 EDT

Latest chemotherapy Stories

2013-06-02 23:15:45

Voices Against Brain Cancer comments on a potential new target that gives promise for treating glioblastomas. New York, NY (PRWEB) June 01, 2013 On June 1, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a possible new target that may enhance brain cancer treatment. According to a Futurity.org article, researchers are working on targeting a specific enzyme that may be able to inhibit and kill glioblastoma cells and other forms of...

2013-05-31 12:24:08

IRVINE, Calif., May 31, 2013 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that results from five studies focused on breast, colon and colorectal cancer will be presented at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting to be held May 31-June 4, 2013 at McCormick Place in Chicago. Of particular importance are the studies which demonstrate that molecular subtyping allows for improvement in therapy selection and overall...

2013-05-31 08:25:09

PORTSMOUTH, N.H., May 31, 2013 /PRNewswire/ -- Novocure, a commercial stage private oncology company, announced today that data from pre-clinical and clinical studies evaluating NovoTTF(TM) Therapy will be presented and published online as part of the 49th Annual Meeting of the American Society for Clinical Oncology (ASCO) in Chicago, IL, May 31-June 4, 2013. The clinical data includes a detailed analysis of time to tumor progression for patients with recurrent glioblastoma treated with...

2013-05-30 23:25:20

CureMD announced today its plans to create a new technology paradigm in the Oncology field by offering medical oncologists and their staffs an affordable Cloud Based solution to automate all clinical, administrative, and financial aspects of their busy practices. New York, NY (PRWEB) May 30, 2013 CureMD, a healthcare technology company with headquarters in New York City, has recently completed a 5 year development project which has resulted in the industry´s first and only...

Melanoma Treatments Receive FDA Approval
2013-05-30 12:43:33

redOrbit Staff & Wire Reports - Your Universe Online The US Food and Drug Administration (FDA) has approved two new medicines used to treat the most dangerous form of skin cancer, as well as a genetic test developed alongside those drugs. The two new medications, both of which are manufactured by GlaxoSmithKline (GSK), are dabrafenib (which will be marketed as Tafinlar) and trametinib (which will be sold under the name Mekinist). They will be used to treat patients with advanced...

2013-05-29 08:30:11

~New indication provides physicians with option to be used earlier in treatment of the disease, with hope of delaying chemotherapy~ TORONTO, May 29, 2013 /CNW/ - Janssen Inc. announced today that Health Canada has approved the once-daily, oral medication ZYTIGA(®) (abiraterone acetate), for use in combination with prednisone for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in patients who are asymptomatic or mildly symptomatic after failure of androgen...

2013-05-25 23:01:33

Voices Against Brain Cancer comments on a new study that shows cold plasma´s success against brain cancer cells. New York, NY (PRWEB) May 25, 2013 On May 25, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a new study by the Max Planck Institute for Extraterrestrial Physics, that shows incorporating cold atmospheric plasma into brain cancer treatment may help when dealing with glioblastoma cells. According to a Science Daily...

2013-05-23 16:26:03

Genomic Testing Information for Breast Cancer Patients Now Available on New Website and Facebook Page IRVINE, Calif., May 23, 2013 /PRNewswire/ -- More than half of women diagnosed with early stage breast cancer may not benefit from chemotherapy and still have excellent outcomes. To educate women, Agendia, Inc. has announced the launch of one of the largest sources of online consumer information about breast cancer genomic tests. The new website and interactive Facebook page provide...

2013-05-23 12:26:45

WASHINGTON, May 23, 2013 /PRNewswire-USNewswire/ -- Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added heart toxicity, according to the results of a study published online today in Blood, the Journal of the American Society of Hematology (ASH). Acute myeloid leukemia (AML), the second most common form of leukemia in...

2013-05-23 08:26:41

OGX-427 ORCA(TM) Program Expands to Include Second Phase 2 Trial in Patients with Advanced Lung Cancer BOTHELL, Wash. and VANCOUVER, British Columbia, May 23, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced plans for the initiation of the Cedar(TM) clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer. This trial will be the...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »